Article

Development of non-alcoholic steatohepatitis is associated with gut microbiota but not oxysterol synthesis

2022-12-02

Abstract excerpt

Liver steatosis is the most frequent liver disorder and its advanced stage, non-alcoholic steatohepatitis (NASH), will soon become the main reason for liver fibrosis and cirrhosis. The “multiple hits hypothesis” suggests that progression from simple steatosis to NASH is triggered by multiple factors including the gut microbiota composition. The Epstein Barr virus induced gene 2 (EBI2) is a receptor for the oxyster...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: cdf169b5-7f8c-507f-84ca-e596b2a12c81
DOI: 10.1101/2022.12.02.518833

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Development of non-alcoholic steatohepatitis is associated with gut microbiota but not oxysterol synthesisDOI 10.1101/2022.12.02.518833Read

Imbalanced gut microbiota predicts and drives the progression of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in a fast-food diet mouse modelSemantic proximity Read

Adlercreutzia equolifaciens Is an Anti-Inflammatory Commensal Bacterium with Decreased Abundance in Gut Microbiota of Patients with Metabolic Liver DiseaseSemantic proximity Read

Disrupted Host-Microbiota Crosstalk Promotes Nonalcoholic Fatty Liver Disease Progression by Impaired MitophagySemantic proximity Read

The Role of the Intestinal Microbiota in Nonalcoholic SteatohepatitisSemantic proximity Read

Gut microbiota induced epigenetic modifications in the non‐alcoholic fatty liver disease pathogenesisSemantic proximity Read

The Influence of the Microbiome on NAFLD and NASHSemantic proximity Read

Modeling dysbiosis of human NASH in mice: Loss of gut microbiome diversity and overgrowth of Erysipelotrichales.Semantic proximity Read

Longitudinal analysis of a dietary mouse model of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)Semantic proximity Read

Establishment of animal models for NASH and utilization for mining associated gut microbiotaSemantic proximity Read

Discovery biomarker to optimize obeticholic acid treatment for non-alcoholic fatty liver diseaseSemantic proximity Read

Modulation of hepatic mRNA-miRNA panel linked to NAFLD/NASH Hippo signaling and gut microbiota after administration of kefir in Non-Alcoholic Steatohepatitis Rat ModelSemantic proximity Read

Host ALDH2 deficiency aggravates nonalcoholic steatohepatitis through gut-liver axisSemantic proximity Read